CRISPR-Cas9 may inadvertently increase cancer risk in treated cells, according to a new study from researchers at Cambridge University and the Karolinska Institutet.
Oncology is the most advanced area in genomics right now. The field is setting the standard for other indications to follow and improve upon.
Researchers have discovered that tumour cells reprogram metabolic pathways to gain control over a type of immune cell that allows cancer growth.
A patient with metastatic breast cancer has made a dramatic recovery after receiving a personalised therapy using her own cells.
New research may explain the link between a high level of iron in the body and prostate cancer.
A 21-gene test performed on tumours could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study.
Activating an olfactory receptor in prostate cancer cells causes them to morph into a more aggressive form.
Michigan based researchers identify long noncoding RNA transcript as important molecule in prostate cancer progression. If you’re new to noncoding RNAs and cancer, this might be useful to read first!
Although reprogrammed viruses are commonly used in gene therapy to treat diseases, this virus can do its work without affecting healthy cells.
A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia, and that the disease might be preventable.